bravecto 1-month vs 3 month


Visit ourwebsite for pet parents. To help ensure that the dog does not vomit again, it is suggested to wait 24 hours until redosing. Aids in the treatment of colds, respiratory illness, scaly legs and eye worms. They count on Merck Animal Health for information, technologies and veterinary services that truly advance animal healthcare. Use with caution in cats that are heartworm positive.

Serenity Aquatics Tropical Weekend Feeder Blocks 4 Pack. Chewy gets it to us quickly with no hassle. Seizures have been reported in dogs BRAVECTO 1-MONTH email template that can be used by your clinic. This new product is suitable for dogs in the early stages of life to begin a regimen of monthly flea and tick protection. In todays highly competitive markets we need to invest heavily to achieve success with tomorrows products. Reference: 1.

receiving isoxazoline class drugs, even in dogs without a history of seizures. BRAVECTO 1-MONTH is expected to be available in the coming months. Treatment and Control of Tick Infestations: In well-controlled laboratory studies in dogs 8 weeks of age and older, Bravecto 1-Month demonstrated 97.7% effectiveness against Rhipicephalus sanguineus ticks at 48 hours after treatment or infestation for 30 days. >> myPet MagazineDesigned simply to share our love and knowledge of pets with all. Portfolio Expansion Ensures Dogs and Puppies 8 Weeks of Age and Older Receive Early, Broad-Spectrum Protection Against Fleas and Ticks. In a US field study where dogs were treated at home, over 93% of dogs ate the chew voluntarily-either by itself or with food. Treatment and control of paralysis tick for 1 month. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. BRAVECTO 1-MONTH Chews for Dogs and Puppies, BRAVECTO 1-MONTH Chews for Dogs and Puppies. Millsboro, DE: Intervet, Inc; 2020. Through its commitment to The Science of Healthier Animals, Merck Animal Health offers veterinarians, farmers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of digitally connected identification, traceability and monitoring products. So thrilled to be able to give the same to my pup. Keep Bravecto 1-Month in a secure location out of reach of Our broad portfolio of vaccines and pharmaceutical medicines help maintain and improve animal health. For dogs six months and older, it also controls and treats lone star tick infestations. Fluralaner is a member of the isoxazoline class. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, decreased appetite, diarrhea, lethargy, polydipsia, and flatulence. No adverse reactions were observed from the concurrent use of Bravecto 1-Month with other medications. supply), Sentinel Tablet for Dogs, 26-50 lbs, (Yellow Box), 6 Tablets (6-mos.

Copyright 2022 Today's Veterinary BusinessWeb DesignbyPHOS Creative. supply), Nutri-Vet Fresh Pumpkin + SuperBlend Flavored Puree Digestive Supplement for Cats & Dogs, 4 count, Small Breeds, Medium Breeds, Large Breeds. BRAVECTO 1-MONTH is an important addition to the companys parasiticide portfolio, which are extended duration flea and tick protection products that offer broad-spectrum, comprehensive parasite protection for dogs. Bravecto 1-Month should be administered with food. The product is administered as a single, monthly flavored chew formulation for treatment and prevention of fleas and treatment and control of ticks. In well-controlled laboratory effectiveness studies, one dog and three puppies administered Bravecto 1-Month had diarrhea (with or without blood). Fluralaner, a novel isoxazoline, prevents flea (Ctenocephalides felis) reproduction in vitro and in a simulated home environment. product.

A nutrient enhanced insect food for reptiles, animals and birds.

Fluralaner is a member of the isoxazoline class. Keep this and all drugs out of the reach of children. With Bravecto 1-Month, we have expanded our portfolio with a superior advance in the fight against parasites, as well as provided both adult dogs and puppies with flea and tick protection that delivers immediate and persistent killing activity, said K.J.

Bravecto 1-Month kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick), Dermacentor variabilis (American dog tick) and Rhipicephalus sanguineus (brown dog tick)] for one month in dogs and puppies 8 weeks of age and older, and weighing 4.4 pounds or greater. Contents: 1 chew containing 45 mg fluralaner Approved by FDA under NADA # 141-532, Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Bravecto 1-Month is not effective against A. americanum in puppies less than 6 months of age (see Effectiveness). At Merck Animal Health we never lose sight of the fact that innovation is the lifeblood of our industry. BRAVECTO 1-MONTH (fluralaner) Chews [product label]. These statements are based upon the current beliefs and expectations of the companys management and are subject to significant risks and uncertainties.

If you suspect that a side effect has taken place as a result of giving the dog BRAVECTO, please report it to Merck Technical Services at 1-800-224-5318, and follow any advice that they provide.

These complementary products will cover the seven common, harmful parasites that affect dogs inside and out by preventing ticks and multiple stages of the flea lifecycle, including eggs and adult fleas, as well as treating and controlling all common intestinal parasites, including roundworms, hookworms, whipworms and tapeworms and preventing heartworm disease.

Do not use in cases of hypersensitivity to the active constituent or to any of the excipients.

The manufacturer, Merck Animal Health, did not announce a launch date for the product, which like other Bravecto preventives contains the active ingredient fluralaner, an ectoparasiticide belonging to the isoxazoline class. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or online at http://www.FDA.gov/reportanimalae. Effective treatment and control of demodex mite. BRAVECTO 1-MONTH animated social media advertisements that can be used by your clinic. BRAVECTO is approved for use in breeding, pregnant, and lactating dogs. Not for human use. decreased appetite, elevated ALT, lethargy, and weight loss. There were no clinically-relevant, treatment-related effects on body weights, food consumption, organ weights, hematology, C-reactive protein, coagulation profile, urinalysis, gross pathology and histopathology. Fluralaner is a member of the isoxazoline class. An overview of BRAVECTO 1-MONTH Chews, outlining how to start your puppy patients on BRAVECTO. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. Bravecto 1 Month should be administered monthly until the absence of mites is confirmed by two consecutive monthly skin scrapings. Lustre VetA pleasantly fragranced cologne that conditions the coat while deodorising. 3 months vs monthly is a huge difference. The following abnormalities were noted in 7 pups from 2 of the 10 dams in only the treated group during gross necropsy examination: limb deformity (4 pups), enlarged heart (2 pups), enlarged spleen (3 pups), and cleft palate (2 pups). For more information, visit www.merck-animal-health.com or connect with us on LinkedIn, Facebook, and Twitter at @MerckAH. Large blocks that slowly dissolve and release quality fish food for your pet while you are away. infestations for one month in dogs and puppies 6 months of As your puppy patients grow up, you can easily transition them from BRAVECTO 1-MONTH Chews to extended-duration BRAVECTO Chewsthis improves the likelihood of compliance, because of the multiple-month protection that extended-duration BRAVECTO Chews provide in a single dose. Kills insects on contact. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Do not eat, drink or smoke while handling the product.

Phone Australia 131 126. The safety of Bravecto 1-Month has not been evaluated in breeding, pregnant and lactating dogs (see Animal Safety). Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA. Our pharmacy prepares and ships prescription medications separately to ensure proper handling. BRAVECTO Chewshave not been shown to be effective for 12-weeks duration in puppies less than 6 months of age. Merck Sharp & Dohme Corp. Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Bravecto 1 Month is available as a tasty pork flavoured chew in single dose packs. First Aid If poisoning occurs, contact a doctor or Poisons Information Centre. Add content to this section using the sidebar. Pet owners now can begin their dogs early life experience on this monthly product and have the option to easily transition to the extended duration BRAVECTO products as the dog reaches 6 months of age, helping to ensure consistent treatment and compliance. Stay current with the latest techniques and information Sign up below to start your FREE Todays Veterinary Business subscription today. Copyright 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. This class has To report suspected adverse events, for technical assistance or to obtain a copy of the Safety Data Sheet (SDS), contact Merck Animal Health at 1-800-224-5318. Diarrhea and mucoid or discolored feces were the most common observations, occurring at a similar incidence in the treated and control groups. May irritate the eyes and skin. supply), Bravecto 1-Month Chew for Dogs, 44-88 lbs, (Blue Box), 1 Chew (1-mo. Not for human use. Tremors were noted in one dog in each of the 3 fluralaner dose groups on Day 1 at 4 hours post-dose. Vomiting was noted in one dog in the 5 group and one dog in the control group on Day 2. supply), Bravecto 1-Month Chew for Dogs, 9.9-22 lbs, (Orange Box), 1 Chew (1-mo. Administered orally as a single The dogs in the control group were untreated. Sure Petcare, the pet technology specialist, provides pet products that empower owners to care for their pets in entirely new ways. See back panel for age related indications in dogs and puppies 6 months of age and older. Made from powdered bovine colostrum with added lactalbumin, omega-3 and omega-6 fatty acids, vitamins and minerals.

or neurologic disorders. Treatment with Bravecto 1-Month may begin at any time of the year and can continue year-round without interruption. Interceptor Plus Chew for Dogs, 25.1-50 lbs, (Yellow Box), 1 Chew (1-mo. For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at1-800-224-5318.This site is intended for veterinary professionals. We'll collect your pet and vet information to verify this prescription before shipping. BRAVECTO Chew should be given with food. Do not eat, drink or smoke while handling the

With a prescription strength for dogs weighing 22 to 44 pounds, this single-use treatment will defend your best friend from fleas and ticks for one month. This product is not recommended for use in breeding, pregnant or lactating dogs. INDICATIONS:BRAVECTO 1-MONTH Chews kill adult fleas and are indicated for the treatment and prevention of flea infestations(Ctenocephalides felis) and the treatment and control of tick infestations (Ixodes scapularis [black-legged tick], Dermacentor variabilis [American dog tick], and Rhipicephalus sanguineus [brown dog tick]) for one month in dogs and puppies 8 weeks of age and older, and weighing 4.4 pounds or greater. Bravecto 1-Month (fluralaner) is a flavored chew formulated to provide a minimum dose of 4.5 mg/lb (10 mg/kg) body weight of fluralaner. The following adverse events are based on post-approval adverse drug experience reporting for fluralaner. Blood urea nitrogen (BUN) was elevated in one dog in the 3 group on Day 8. One dog in the control group with no history of seizures had seizure activity 12 days after its second dose. Effective against fipronil-resistant strains of fleas.

Wash hands thoroughly with soap and water dogs, cats, and other animals to prevent accidental ingestion Our Animal Health portfolio reflects our unwavering commitment to R&D. Private Securities Litigation Reform Act of 1995. If 4 or more hours have passed before the vomiting occurs, it is likely that the medication has been absorbed and the dog is protected. BRAVECTO 1-MONTH kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick), Dermacentor variabilis (American dog tick) and Rhipicephalus sanguineus (brown dog tick)] for one month in dogs and puppies 8 weeks of age and older and weighing 4.4 pounds or greater. BRAVECTO Topical Solution for Cats: Side effects may include vomiting,itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. Trembling was noted in one dog in the 1 group on Day 2. felis) and the treatment and control of tick infestations [Ixodes Guaranteed genuine and backed by the manufacturer. It is our heritage and our mission. Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. We can answer all your questions and get you started with prescribing BRAVECTO 1-MONTH Chews for the dogs and puppies in your care.

Maintains persistent efficacy against tick re-infestations for 5 weeks (35 days) following administration. Treatment and control of brown dog tick for 1 month.

age and older, and weighing 4.4 pounds or greater. BRAVECTO Topical Solution for Dogs: Side effects may include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash.

In well-controlled laboratory studies in dogs 6 months of age and older, Bravecto 1-Month demonstrated >96% effectiveness against Amblyomma americanum at 48- and 72-hours after treatment or infestation for 31 days. Wash hands thoroughly with soap and water immediately after use of the product. Bravecto 1-Month failed to demonstrate >90% effectiveness against Amblyomma americanum in 8-week-old puppies. children. MADISON, N.J., July 9, 2020 Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK), today announced the U.S. Food and Drug Administrations approval of BRAVECTO 1-MONTH (fluralaner) Chews for dogs and puppies 8 weeks of age and older. We offer innovative programs and technical services to help protect the health of animals and support safe and affordable food supplies. Looking forward to getting g both in the same schedule. Side effects may include itching, diarrhea, vomiting, All you have to do is sign up here (and renew each year). Due to reduced drug bioavailability in the fasted state, Bravecto 1-Month should be administered with food. There were no clinically-relevant, treatment-related effects on the body weights, food consumption, reproductive performance, semen analysis, litter data, gross necropsy (adult dogs) or histopathology findings (adult dogs and puppies). The content of fluralaner in each size chew is 54.6 g/kg. BRAVECTO 1-MONTHChews are for dogs 8 weeks of age and older. Treatment and Prevention of Flea Infestations: In well-controlled laboratory studies in dogs 6 months of age and older, Bravecto 1-Month started killing fleas within 4 hours after treatment and was > 99% effective by 12 hours after treatment or post-infestation for 35 days. BUN and serum creatinine were elevated in one dog in the 5 group on Day 85. Fluralaner was administered orally to intact, reproductively-sound male and female Beagles at a dose of up to 168 mg/kg on three to four occasions at 8-week intervals. In a well-controlled 90-day U.S. field study conducted in households with existing flea infestations, the effectiveness of Bravecto 1-Month against fleas on Day 30, 60, and 90 visits compared with baseline was 99.6%, 99.9%, and 99.9%, respectively. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures.

If vomiting occurs, check with your vet to decide whether to redose or not; however, if an otherwise healthy dog vomits within 3 hours of receiving BRAVECTO , it is recommended that the dog be redosed. Bravecto 1-Month is also indicated for the treatment and During veterinary examination at Week 7, two pups from the control group had inguinal testicles, and two and four pups from the treated group had inguinal and cryptorchid testicles, respectively. BRAVECTO Chews for Dogs: Side effects may include vomiting, decreased appetite, diarrhea, lethargy, excessive thirst and flatulence. BRAVECTO 1-MONTH contains fluralaner, an ectoparasiticide belonging to the isoxazoline class, which has systemic activity against ticks and fleas.

The mode of action of fluralaner is the antagonism of the ligand-gated chloride channels (gamma-aminobutyric acid (GABA)-receptor and glutamate-receptor). The elimination half-life ranges from 5.0 to 8.5 days for puppies and 12.6 to 15.7 days for adult dogs. Thank you Chewy! Parasites & Vectors (2014) 7:275. Collies with the defect were administered 3 times the deliverable dose and had no adverse events. The BRAVECTO product line, which are our extended duration flea and tick protection products, and the SENTINEL branded products, which control all common intestinal parasites, provide broad-spectrum, year-round comprehensive internal and external parasite protection for dogs.

Parasites pose serious animal and human health risks as fleas and ticks can transmit disease, said Christine Royal, DVM, executive director, U.S. Companion Animal and Equine Professional Services, Merck Animal Health. Palatability was not assessed in the control group. immediately after use of the product. In a well-controlled laboratory study in dogs 8 weeks of age and older, Bravecto 1-Month demonstrated 100% effectiveness against fleas for 30 days. Abnormal salivation was observed on 17 occasions: in six treated dogs (11 occasions) after dosing and four control dogs (6 occasions). The approval of this additional BRAVECTO product builds on the strong foundation and body of scientific evidence that we have established over the years with our broad-spectrum, comprehensive line of parasite protection products, said KJ Varma, BVSc, PhD, senior vice president, Research and Development, Merck Animal Health. BRAVECTO products are only available through licensed veterinarians. treatment and control of demodicosis (demodectic mange) caused by Demodex sp. We'll collect your pet's prescription information at Checkout. Vetafarm Origins Insect & Mite Liquidator. Bravecto 1-Month is also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for one month in dogs and puppies 6 months of age and older, and weighing 4.4 pounds or greater. Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product. The topical product and Bravecto Plus, another spot-on preventive, are formulated for cats. 6 weeks protection. Our customers have always known that they can depend on Merck Animal Health for more than just medicines. KONG Tropics FlamingoLong legs to hunt and a pineapple to bat around means hours of fun.

If a chew is broken or crumbles, make sure your dog still receives the whole dose. Product may be packaged in 1, 3, or 4 chews per package. If the vomiting repeats again, DO NOT give a third chew, and call your veterinarian.

Use with caution in dogs with a history of seizures or neurologic disorders. Fluralaner is an inhibitor of the arthropod nervous system.

Contact us for more information about BRAVECTO 1-MONTH Chews. Bravecto 1-Month kills adult fleas and is indicated for the Use with caution in dogs with a history of seizures or neurologic disorders. In a well-controlled field study Bravecto 1-Month was used concurrently with other medications, such as vaccines, anthelmintics, antibiotics (including topicals), steroids, analgesics, and anesthetics. In a well-controlled laboratory study, BRAVECTO was shown to be safe in collies known to be MDR-1 gene deficient. Varma, BVSc, Ph.D., senior vice president of research and development at Merck Animal Health. Administer Bravecto 1 Month at or around the time of feeding. Provides effective control of pre-existing infestations of paralysis ticks (Ixodes holocyclus) within 24 hours. Founded in 2007, we have developed an award-winning range of microchip-operated pet doors and feeders, which solve many problems commonly experienced by pet owners. Fluralaner is for systemic use and belongs to the class of isoxazoline-substituted benzamide derivatives. [i] Williams et al. It is not always possible to reliably estimate the adverse event frequency or establish a causal relationship to product exposure using these data. Reproductive safety was evaluated for fluralaner, the active ingredient in BRAVECTO 1-Month. The dog was started on anticonvulsant medication and no additional seizures occurred during the study. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Kenilworth, NJ USA.

On July 2, 2020, Merck Animal Health announced the completion of its product acquisition for the U.S. rights to SENTINEL FLAVOR TABS and SENTINEL SPECTRUM Chews in the Companion Animal category. Makes tap water safe for fish by neutralising harmful chlorine and chloramines. For dogs weighing more than 40 kg, use a combination of two tablets that most closely matches the body weight. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. All rights reserved. Peak fluralaner concentrations are achieved between 1 and 3 days following single or multiple oral administrations of Bravecto 1-Month to young puppies and adult dogs. BRAVECTO 1-MONTHChews are not effective againstA.americanumin puppies less than 6 months of age. My 4 year old takes it year round and she couldnt be healthier and more protected. With BRAVECTO 1-MONTH, we have expanded our portfolio with a superior advance in the fight against parasites, as well as provided both adult dogs and puppies with flea and tick protection that delivers immediate and persistent killing activity.. Yours FREE with every order.

Contents: 1 chew containing 200 mg fluralaner Approved by FDA under NADA # 141-532, Caution: Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. Not all adverse events are reported to FDA/CVM.

This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Use with caution in cats with a history of neurologic disorders. This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the company) includes forward-looking statements within the meaning of the safe harbor provisions of the U.S. No additional seizures occurred during the study.

Thats why choosing the right protection is so important. In addition to all the cuteness, there comes some hard work and even the occasional fleas and ticks! >> Help CentreOur online knowledge base full of articles, FAQs, shopping help and loads ofuseful pet care info. For paralysis tick control it is recommended that Bravecto 1 Month be used in conjunction with daily searching for, and removal of, any ticks found as the risk of tick paralysis cannot be entirely eliminated. Fluralaner is a member of the isoxazoline class. BRAVECTO 1-MONTH social media posts that can be used by your clinic. Rapid onset of action kills newly emerged adult fleas before they lay eggs. >>myPet PodcastPerfect for the busy pet owner; offering tips, tricks and reliable pet care education on the go. In a well-controlled U.S. field study, which included 271 dogs (201 dogs were administered Bravecto 1-Month every 30 days and 70 dogs were administered an oral active control [an isoxazoline] every 30 days), there were no serious adverse reactions associated with treatment. During the palatability assessment, four dogs coughed within 1 hour of dosing with Bravecto 1-Month. older, and weighing 4.4 pounds or greater. Dogs as young as 8 weeks old can be protected from fleas and ticks through the use of Bravecto 1-Month, a chewable medication newly approved by the U.S. Food and Drug Administration. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures.

Read Articles Written by Todays Veterinary Business Staff. BRAVECTO 1-MONTH Chews are also indicated for the treatment and control of Amblyomma americanum (lone star tick) infestations for one month in dogs and puppies 6 months of age and older, and weighing 4.4 pounds or greater. I have 7 dogs and without Bravecto my dogs wouldnt be flea free! Kelato AppeTITEDesigned to increase the appetite of horses that are picky eaters or are off feed due to stress. Medications ship separately. Copyright 2020 Intervet Inc, a subsidiary of Merck & Company Inc. All rights reserved. Wash hands after use. Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, is the global animal health business unit of Merck.

Keep Bravecto 1-Month in a secure location out of reach of dogs, cats, and other animals to prevent accidental ingestion or overdose. Bravecto 1-Month should be administered orally as a single dose monthly according to the Dosage Schedule below to provide a minimum dose of 4.5 mg/lb (10 mg/kg) fluralaner. The result is a pipeline, which in terms of size and quality, provides us with a solid platform for consistent growth in veterinary vaccines and pharmaceuticals. Over the 90-day study period, all observations of potential adverse reactions were recorded. One adult dog in the treated group suffered a seizure during the course of the study (46 days after the third treatment). Bravecto 1-Month is available in five strengths (45, 100, 200, 400, and 560 mg fluralaner per chew).

>> YouTubePet care advice, step-by-step guides, product road tests and reviews from our team of experts. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful.